Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Gemcitabine
Most Correlated Studies
- Acquired gemcitabine-resistance in pancreatic cancer cell lines
- Peripheral blood mononuclear cells in NSCLC patients treated with first line chemotherapy
- Pancreatic cancer in KPC mouse model after CTGF inhibition and gemcitabine treatment
- Peripheral blood mononuclear cells (PBMC) from non-small cell lung cancer (NSCLC) patients
- B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
Most Relevant Literature
- H-gemcitabine: a new gemcitabine prodrug for treating cancer.
- Gemcitabine versus Modified Gemcitabine: a review of several promising chemical modifications.
- Gemcitabine-induced pulmonary toxicity.
- Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabi…
- Gemcitabine-associated "pseudocellulitis" and "pseudosepsis": a case report and review of the litera…
Most Relevant Clinical Trials
- AZD6738 & Gemcitabine as Combination Therapy
- Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine
- Tivozanib + Gemcitabine in Metastatic RCC
- Gemcitabine With Ascorbate Including Adolescents
- GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
